DREW HEIPLE
- Type
- Physician · Allopathic & Osteopathic Physicians / Internal Medicine / Nephrology
- Where
- RUSSELLVILLE, AR
- NPI
- 1376665646
- Received
- $236,463 in 542 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 106 | $74,204 |
| 2024 | General payment | 117 | $53,007 |
| 2023 | General payment | 133 | $57,821 |
| 2022 | General payment | 108 | $35,820 |
| 2021 | General payment | 53 | $9,142 |
| 2020 | General payment | 16 | $6,225 |
| 2019 | General payment | 9 | $242 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 91 | $205,343 |
| Travel and Lodging | 100 | $18,494 |
| Food and Beverage | 318 | $9,956 |
| Honoraria | 1 | $2,160 |
| Education | 32 | $508 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-11 | Travere Therapeutics, Inc. | $39 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-12-10 | Fresenius USA Marketing, Inc. | $23 | Food and Beverage | In-kind items and services | VELPHORO Drug, Phosphate binder for ESRD | 2025 | |
| 2025-12-02 | Amgen Inc. | $17 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-11-17 | AstraZeneca Pharmaceuticals LP | $3,290 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LOKELMA Drug, Cardiovascular and Metabolism | 2025 | |
| 2025-11-12 | Novartis Pharmaceuticals Corporation | $19 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-11-10 | Travere Therapeutics, Inc. | $10 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-11-07 | AstraZeneca Pharmaceuticals LP | $175 | Travel and Lodging | In-kind items and services | LOKELMA Drug, Cardiovascular and Metabolism | 2025 | |
| 2025-11-07 | AstraZeneca Pharmaceuticals LP | $23 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2025 | |
| 2025-11-06 | Amgen Inc. | $26 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-11-05 | Novartis Pharmaceuticals Corporation | $19 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-10-22 | Amgen Inc. | $15 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-10-16 | Novartis Pharmaceuticals Corporation | $18 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-10-16 | Travere Therapeutics, Inc. | $10 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-10-15 | Boehringer Ingelheim Pharmaceuticals, Inc. | $18 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-10-14 | Bayer Healthcare Pharmaceuticals Inc. | $15 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-10-07 | Novo Nordisk Inc | $579 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-10-02 | Novo Nordisk Inc | $4,496 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-10-02 | Novo Nordisk Inc | $4,496 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-10-02 | Novo Nordisk Inc | $297 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-10-02 | Novo Nordisk Inc | $181 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-10-02 | Novo Nordisk Inc | $181 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-10-02 | Novo Nordisk Inc | $146 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-10-02 | Novo Nordisk Inc | $67 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-10-02 | Novo Nordisk Inc | $50 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-09-19 | Novo Nordisk Inc | $5,586 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-09-19 | Novo Nordisk Inc | $336 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-09-19 | Novo Nordisk Inc | $140 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-09-19 | Novo Nordisk Inc | $29 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-09-18 | Novo Nordisk Inc | $5,586 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-09-18 | Novo Nordisk Inc | $336 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-09-18 | Novo Nordisk Inc | $167 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-09-18 | Novo Nordisk Inc | $140 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-09-18 | Novo Nordisk Inc | $125 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-09-11 | Novo Nordisk Inc | $32 | Education | In-kind items and services | Drug | 2025 | |
| 2025-09-11 | Calliditas Therapeutics US Inc. | $18 | Food and Beverage | In-kind items and services | TARPEYO Drug, NEPHROLOGY | 2025 | |
| 2025-09-10 | scPharmaceuticals Inc. | $16 | Food and Beverage | In-kind items and services | FUROSCIX Drug, Cardiology | 2025 | |
| 2025-09-04 | Boehringer Ingelheim Pharmaceuticals, Inc. | $14 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-09-03 | Travere Therapeutics, Inc. | $7 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-02 | Amgen Inc. | $21 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-08-28 | Novartis Pharmaceuticals Corporation | $19 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-08-21 | AstraZeneca Pharmaceuticals LP | $14 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2025 | |
| 2025-08-19 | Amgen Inc. | $14 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-08-14 | Vifor Pharma, Inc. | $23 | Food and Beverage | In-kind items and services | Veltassa Drug, Nephrology | 2025 | |
| 2025-08-13 | Mallinckrodt Hospital Products Inc. | $30 | Food and Beverage | In-kind items and services | ACTHAR Biological, IMMUNOLOGY | 2025 | |
| 2025-08-12 | Bayer Healthcare Pharmaceuticals Inc. | $15 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-08-05 | Travere Therapeutics, Inc. | $37 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-08-05 | Travere Therapeutics, Inc. | $2 | Education | In-kind items and services | Filspari Drug, Kidney Disease | 2025 | |
| 2025-08-04 | scPharmaceuticals Inc. | $15 | Food and Beverage | In-kind items and services | FUROSCIX Drug, Cardiology | 2025 | |
| 2025-07-29 | Novartis Pharmaceuticals Corporation | $23 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-07-24 | Novo Nordisk Inc | $5,858 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-07-24 | Novo Nordisk Inc | $1,257 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-07-24 | Novo Nordisk Inc | $390 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-07-24 | Novo Nordisk Inc | $261 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-07-24 | Novo Nordisk Inc | $148 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-07-22 | Travere Therapeutics, Inc. | $30 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-07-15 | AKEBIA THERAPEUTICS INC | $14 | Food and Beverage | In-kind items and services | Vafseo Drug, Nephrology | 2025 | |
| 2025-07-03 | scPharmaceuticals Inc. | $14 | Food and Beverage | In-kind items and services | FUROSCIX Drug, Cardiology | 2025 | |
| 2025-07-02 | Travere Therapeutics, Inc. | $36 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-06-30 | Otsuka America Pharmaceutical, Inc. | $29 | Food and Beverage | In-kind items and services | JYNARQUE Drug, NEPHROLOGY | 2025 | |
| 2025-06-18 | Travere Therapeutics, Inc. | $11 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-06-17 | Novo Nordisk Inc | $5,313 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-06-17 | Novo Nordisk Inc | $124 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-06-17 | Novo Nordisk Inc | $53 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-06-16 | Amgen Inc. | $20 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-06-12 | Novo Nordisk Inc | $1,090 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-06-05 | Novo Nordisk Inc | $5,586 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-06-05 | Novo Nordisk Inc | $253 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-06-05 | Novo Nordisk Inc | $118 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-06-02 | AKEBIA THERAPEUTICS INC | $21 | Food and Beverage | In-kind items and services | Vafseo Drug, Nephrology | 2025 | |
| 2025-05-30 | AstraZeneca Pharmaceuticals LP | $3,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LOKELMA Drug, Cardiovascular and Metabolism | 2025 | |
| 2025-05-29 | Novo Nordisk Inc | $4,496 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-05-29 | Novo Nordisk Inc | $434 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-05-29 | Novo Nordisk Inc | $122 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-05-28 | Travere Therapeutics, Inc. | $26 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-05-22 | AstraZeneca Pharmaceuticals LP | $171 | Travel and Lodging | In-kind items and services | LOKELMA Drug, Cardiovascular and Metabolism | 2025 | |
| 2025-05-22 | AstraZeneca Pharmaceuticals LP | $122 | Food and Beverage | In-kind items and services | LOKELMA Drug, Cardiovascular and Metabolism | 2025 | |
| 2025-05-15 | Calliditas Therapeutics US Inc. | $22 | Food and Beverage | In-kind items and services | TARPEYO Drug, NEPHROLOGY | 2025 | |
| 2025-05-13 | Novo Nordisk Inc | $1,362 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-05-07 | Novo Nordisk Inc | $1,090 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-05-07 | Travere Therapeutics, Inc. | $29 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-05-01 | Novo Nordisk Inc | $5,586 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-05-01 | Novo Nordisk Inc | $246 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-05-01 | Novo Nordisk Inc | $119 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-30 | Amgen Inc. | $31 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-04-29 | Amgen Inc. | $30 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-04-15 | Novartis Pharmaceuticals Corporation | $20 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-04-10 | Boehringer Ingelheim Pharmaceuticals, Inc. | $16 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-04-02 | Travere Therapeutics, Inc. | $24 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-04-01 | Bayer Healthcare Pharmaceuticals Inc. | $16 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-03-20 | Bayer Healthcare Pharmaceuticals Inc. | $17 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-03-13 | Novo Nordisk Inc | $26 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-03-08 | Novo Nordisk Inc | $7,575 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-03-08 | Novo Nordisk Inc | $682 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-03-08 | Novo Nordisk Inc | $399 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-03-08 | Novo Nordisk Inc | $298 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-03-08 | Novo Nordisk Inc | $120 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-03-08 | Novo Nordisk Inc | $32 | Education | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-03-07 | Novo Nordisk Inc | $32 | Education | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-03-07 | Novo Nordisk Inc | $32 | Education | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-03-07 | Novo Nordisk Inc | $32 | Education | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-03-05 | Ardelyx, Inc. | $14 | Food and Beverage | In-kind items and services | IBSRELA Drug, GASTROENTEROLOGY | 2025 | |
| 2025-02-25 | Bayer Healthcare Pharmaceuticals Inc. | $17 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-02-17 | Mallinckrodt Hospital Products Inc. | $22 | Food and Beverage | In-kind items and services | ACTHAR Biological, IMMUNOLOGY | 2025 | |
| 2025-01-28 | Novartis Pharmaceuticals Corporation | $20 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-01-21 | AstraZeneca Pharmaceuticals LP | $70 | Food and Beverage (7 payments) | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2025 | |
| 2025-01-08 | Calliditas Therapeutics US Inc. | $28 | Food and Beverage | In-kind items and services | TARPEYO Drug, NEPHROLOGY | 2025 | |
| 2024-12-25 | CorMedix Inc. | $19 | Food and Beverage | In-kind items and services | DefenCath Drug, Catheter Lock Solution | 2024 | |
| 2024-12-04 | Novartis Pharmaceuticals Corporation | $23 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-11-19 | Amgen Inc. | $21 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-11-19 | Amgen Inc. | $19 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-11-12 | Travere Therapeutics, Inc. | $31 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-11-06 | Travere Therapeutics, Inc. | $33 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-10-23 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-10-17 | Bayer Healthcare Pharmaceuticals Inc. | $19 | Education | In-kind items and services | Kerendia Drug, Cardio-renal | 2024 | |
| 2024-10-08 | Ardelyx, Inc. | $26 | Food and Beverage | In-kind items and services | IBSRELA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-10-03 | AstraZeneca Pharmaceuticals LP | $3,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-09-25 | Travere Therapeutics, Inc. | $3 | Education | In-kind items and services | 2024 | ||
| 2024-09-24 | AstraZeneca Pharmaceuticals LP | $3,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LOKELMA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-09-24 | AstraZeneca Pharmaceuticals LP | $125 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-09-24 | AstraZeneca Pharmaceuticals LP | $112 | Travel and Lodging | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-09-19 | AstraZeneca Pharmaceuticals LP | $105 | Travel and Lodging | In-kind items and services | LOKELMA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-09-19 | AstraZeneca Pharmaceuticals LP | $76 | Food and Beverage | In-kind items and services | LOKELMA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-09-18 | Amgen Inc. | $28 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-09-16 | AstraZeneca Pharmaceuticals LP | $13 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-09-05 | Novartis Pharmaceuticals Corporation | $15 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-09-04 | Travere Therapeutics, Inc. | $16 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-09-03 | Travere Therapeutics, Inc. | $16 | Education | In-kind items and services | 2024 | ||
| 2024-09-03 | Travere Therapeutics, Inc. | $4 | Education | In-kind items and services | 2024 | ||
| 2024-08-29 | Ardelyx, Inc. | $26 | Food and Beverage | In-kind items and services | IBSRELA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-08-28 | Travere Therapeutics, Inc. | $148 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-08-27 | Novartis Pharmaceuticals Corporation | $17 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-08-21 | CorMedix Inc. | $19 | Food and Beverage | In-kind items and services | DefenCath Drug, Catheter Lock Solution | 2024 | |
| 2024-08-09 | AstraZeneca Pharmaceuticals LP | $3,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-08-06 | Amgen Inc. | $24 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-08-05 | Amgen Inc. | $32 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-08-01 | AstraZeneca Pharmaceuticals LP | $163 | Travel and Lodging | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-08-01 | AstraZeneca Pharmaceuticals LP | $89 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-07-25 | Bayer Healthcare Pharmaceuticals Inc. | $17 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-renal | 2024 | |
| 2024-07-24 | AstraZeneca Pharmaceuticals LP | $15 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-07-10 | Amgen Inc. | $27 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-06-24 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-06-21 | AstraZeneca Pharmaceuticals LP | $3,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-06-14 | Ardelyx, Inc. | $25 | Food and Beverage | In-kind items and services | IBSRELA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-06-12 | AstraZeneca Pharmaceuticals LP | $168 | Travel and Lodging | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-06-12 | AstraZeneca Pharmaceuticals LP | $124 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-06-12 | AstraZeneca Pharmaceuticals LP | $13 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-06-11 | AstraZeneca Pharmaceuticals LP | $800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-05-29 | Travere Therapeutics, Inc. | $16 | Education | In-kind items and services | 2024 | ||
| 2024-05-29 | Travere Therapeutics, Inc. | $16 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-05-29 | Travere Therapeutics, Inc. | $3 | Education | In-kind items and services | 2024 | ||
| 2024-05-29 | Travere Therapeutics, Inc. | $0 | Education | In-kind items and services | 2024 | ||
| 2024-05-22 | OPKO Pharmaceuticals, LLC | $15 | Education | In-kind items and services | RAYALDEE Drug, NEPHROLOGY | 2024 | |
| 2024-05-15 | Amgen Inc. | $27 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-05-09 | AstraZeneca Pharmaceuticals LP | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-05-09 | AstraZeneca Pharmaceuticals LP | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-05-08 | Travere Therapeutics, Inc. | $2 | Education | In-kind items and services | 2024 | ||
| 2024-05-04 | AstraZeneca Pharmaceuticals LP | $48 | Travel and Lodging | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-05-02 | AstraZeneca Pharmaceuticals LP | $58 | Travel and Lodging | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-05-02 | AstraZeneca Pharmaceuticals LP | $18 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-04-30 | AstraZeneca Pharmaceuticals LP | $2,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-04-30 | AstraZeneca Pharmaceuticals LP | $1,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-04-30 | Bayer Healthcare Pharmaceuticals Inc. | $15 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-renal | 2024 | |
| 2024-04-29 | AstraZeneca Pharmaceuticals LP | $18 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-04-29 | AstraZeneca Pharmaceuticals LP | $3 | Travel and Lodging | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-04-26 | Ardelyx, Inc. | $31 | Food and Beverage | In-kind items and services | IBSRELA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-04-25 | AstraZeneca Pharmaceuticals LP | $105 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-04-25 | AstraZeneca Pharmaceuticals LP | $50 | Travel and Lodging | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-04-24 | AstraZeneca Pharmaceuticals LP | $2,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-04-24 | Travere Therapeutics, Inc. | $20 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-04-24 | Travere Therapeutics, Inc. | $16 | Education | In-kind items and services | 2024 | ||
| 2024-04-24 | Travere Therapeutics, Inc. | $3 | Education | In-kind items and services | 2024 | ||
| 2024-04-24 | Travere Therapeutics, Inc. | $2 | Education | In-kind items and services | 2024 | ||
| 2024-04-23 | AstraZeneca Pharmaceuticals LP | $136 | Travel and Lodging | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-04-23 | AstraZeneca Pharmaceuticals LP | $20 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-04-17 | Mozarc Medical US LLC | $139 | Travel and Lodging | Cash or cash equivalent | ARGYLE Device, DIALYSIS CATHETERS | 2024 | |
| 2024-04-17 | Mozarc Medical US LLC | $139 | Food and Beverage | Cash or cash equivalent | ARGYLE Device, DIALYSIS CATHETERS | 2024 | |
| 2024-04-17 | Mozarc Medical US LLC | $132 | Travel and Lodging | Cash or cash equivalent | ARGYLE Device, DIALYSIS CATHETERS | 2024 | |
| 2024-04-17 | Mozarc Medical US LLC | $127 | Travel and Lodging | Cash or cash equivalent | ARGYLE Device, DIALYSIS CATHETERS | 2024 | |
| 2024-04-15 | Mozarc Medical US LLC | $64 | Travel and Lodging | Cash or cash equivalent | ARGYLE Device, DIALYSIS CATHETERS | 2024 | |
| 2024-04-15 | Mozarc Medical US LLC | $29 | Food and Beverage | Cash or cash equivalent | ARGYLE Device, DIALYSIS CATHETERS | 2024 | |
| 2024-04-15 | Mozarc Medical US LLC | $24 | Food and Beverage | Cash or cash equivalent | ARGYLE Device, DIALYSIS CATHETERS | 2024 | |
| 2024-04-12 | Mozarc Medical US LLC | $120 | Travel and Lodging | Cash or cash equivalent | ARGYLE Device, DIALYSIS CATHETERS | 2024 | |
| 2024-04-11 | AstraZeneca Pharmaceuticals LP | $100 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-04-10 | AstraZeneca Pharmaceuticals LP | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-04-05 | AstraZeneca Pharmaceuticals LP | $3,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-04-03 | AstraZeneca Pharmaceuticals LP | $3,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-04-03 | AstraZeneca Pharmaceuticals LP | $2,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-04-03 | AstraZeneca Pharmaceuticals LP | $60 | Travel and Lodging | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-04-01 | AstraZeneca Pharmaceuticals LP | $3,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LOKELMA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-04-01 | AstraZeneca Pharmaceuticals LP | $2,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LOKELMA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-03-29 | AstraZeneca Pharmaceuticals LP | $169 | Travel and Lodging | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-03-29 | AstraZeneca Pharmaceuticals LP | $14 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-03-28 | AstraZeneca Pharmaceuticals LP | $142 | Travel and Lodging | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-03-28 | AstraZeneca Pharmaceuticals LP | $129 | Travel and Lodging | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-03-28 | AstraZeneca Pharmaceuticals LP | $115 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-03-26 | AstraZeneca Pharmaceuticals LP | $120 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-03-26 | AstraZeneca Pharmaceuticals LP | $111 | Travel and Lodging | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-03-25 | Mozarc Medical US LLC | $522 | Travel and Lodging | Cash or cash equivalent | ARGYLE Device, DIALYSIS CATHETERS | 2024 | |
| 2024-03-25 | Mozarc Medical US LLC | $284 | Travel and Lodging | Cash or cash equivalent | ARGYLE Device, DIALYSIS CATHETERS | 2024 | |
| 2024-03-21 | AstraZeneca Pharmaceuticals LP | $1,022 | Travel and Lodging | In-kind items and services | LOKELMA Drug, Cardiovascular and Metabolism | 2024 |
The latest 200 records of 542.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Russellville, AR, county Pope County, AR, state Arkansas; placed by its city name.
| Measure | Place (city or town) Russellville, AR | County Pope County, AR | State Arkansas |
|---|---|---|---|
| Population B01003 | 29,162 | 64,131 | 3,049,391 |
| Population, 2020 census P1 | 28,940 | 63,381 | 3,011,524 |
| Median age B01002 | 30.6 | 37.0 | 38.5 |
| Under 18 B01001 | 22.6% | 23.1% | 23.1% |
| 65 and over B01001 | 12.7% | 16.5% | 17.6% |
| Households B11001 | 10,399 | 24,348 | 1,205,987 |
| Foreign born B05002 | 8.2% | 4.8% | 5.4% |
| Median household income B19013 | $50,877 | $57,344 | $60,773 |
| Median family income B19113 | $62,518 | $71,184 | $76,968 |
| Per capita income B19301 | $27,697 | $30,572 | $34,225 |
| Poverty rate B17001 | 20.8% | 16.9% | 16.0% |
| Unemployment rate B23025 | 5.9% | 5.1% | 4.9% |
| Civilian labor force B23025 | 13,821 | 29,123 | 1,411,269 |
| Mean commute (minutes) B08013 | 15.7 | 20.1 | 22.5 |
| Bachelor's degree or higher B15003 | 28.8% | 24.7% | 25.7% |
| Housing units B25001 | 11,675 | 27,156 | 1,394,673 |
| Owner-occupied B25003 | 55.4% | 70.4% | 66.4% |
| Renters B25003 | 44.6% | 29.6% | 33.6% |
| Median home value B25077 | $172,400 | $170,100 | $188,000 |
| Median gross rent B25064 | $842 | $859 | $947 |
| White, not Hispanic B03002 | 70.5% | 80.6% | 67.4% |
| Black B03002 | 4.0% | 2.2% | 14.6% |
| Hispanic or Latino B03002 | 18.5% | 11.0% | 9.0% |
| Asian B03002 | 1.2% | 0.8% | 1.6% |
| American Indian and Alaska Native B03002 | 0.1% | 0.2% | 0.3% |
Economy now FRED unemployment 3.9% in Sep 2026 (4.2% a year earlier); per capita personal income $61,697 in 2025, up 31% in five years (+5.2% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Russellville, AR.
Comments